FDA expands treatment in nephrotic syndrome - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA expands treatment in nephrotic syndrome

The indication marks an additional use for a therapy previously approved for certain cancers and active lupus nephritis.

  • By

  • Kathryn Wighton

  • September 28, 2026

  • 2 min

Share

Original Source(s)

FDA expands treatment in nephrotic syndrome

  • by Kathryn Wighton

  • September 28, 2026

Related Content

Nirsevimab may curb RSV severity

Real-world estimates showed protection across emergency, inpatient, and intensive care settings during Canada’s first universal immunization season.

Dana-Farber/Boston Children's Named the Top Pediatric Cancer Program in the Nation for 2026-2027

U.S. News & World Report has recognized Dana-Farber/Boston Children’s Cancer and Blood Disorders Center as the #1 pediatric cancer program in the nation in its 2026-2027 Best Children’s Hospitals report.

  • by

  • September 15, 2026

  • 3 min
Risk of Injury Among Children and Youths Whose Mothers Experienced Violent Injury: A Systematic Review and